Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | +4.34% | +12.50% | -0.39% |
14/05 | Transcript : Acumen Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
08/05 | Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.39% | 222M | |
+25.99% | 49.18B | |
+0.82% | 42.11B | |
+49.96% | 40.37B | |
-5.26% | 28.85B | |
+13.28% | 26.09B | |
-22.21% | 18.71B | |
+8.54% | 13.26B | |
+32.25% | 12.32B | |
+0.39% | 11.99B |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- UBS Adjusts Acumen Pharmaceuticals Price Target to $16 From $27, Maintains Buy Rating